Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Study ID: NCT06561425
Start Date: 2022-03-09
End Date: 2029-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

250

Intervention / Treatment

GLPG5101

Sponsor

Galapagos NV

Source: clinicaltrials.gov

Share:
Add to list

Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation

Study ID: NCT06298357
Start Date: 2024-06-27
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

16

Intervention / Treatment

Immediate Start - Virtual Reality

Delayed Start - Virtual Reality

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Study ID: NCT06482957
Start Date: 2022-04-01
End Date: 2029-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2100

Intervention / Treatment

Surveys

Blood Collection

Saliva Collection

Urine Collection

Stool Collection

Tissue collection

Physical Activity Monitoring

Sponsor

Vanderbilt-Ingram Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

Study ID: NCT03975231
Start Date: 2020-09-14
End Date: 2025-10-04
Study Type

Interventional

Study Phase

Phase1

No. of Participants

6

Intervention / Treatment

Dabrafenib

Intensity-Modulated Radiation Therapy

Trametinib

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Study ID: NCT04262466
Start Date: 2020-02-25
End Date: 2026-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

727

Intervention / Treatment

Brenetafusp

Brenetafusp and pembrolizumab

Brenetafusp and chemotherapy

Brenetafusp and monoclonal antibodies and chemotherapy

Brenetafusp and tebentafusp

Brenetafusp and bevacizumab

Brenetafusp and kinase inhibitors

Sponsor

Immunocore Ltd

Source: clinicaltrials.gov

Share:
Add to list

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Study ID: NCT03161431
Start Date: 2019-06-12
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

77

Intervention / Treatment

SX-682

Pembrolizumab

Sponsor

Syntrix Biosystems, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

Study ID: NCT02446431
Start Date: 2014-07
End Date: 2029-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

Infinite

Cyclophosphamide

Valproic Acid

Tmsirolimus

Sponsor

Miller Children's & Women's Hospital Long Beach

Source: clinicaltrials.gov

Share:
Add to list

Pancreatic Cancer Screening for At-risk Individuals

Study ID: NCT05006131
Start Date: 2020-07-10
End Date: 2032-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1395

Intervention / Treatment

Screening for pancreatic cancer

Sponsor

Beth Israel Deaconess Medical Center

Source: clinicaltrials.gov

Share:
Add to list

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Study ID: NCT06295731
Start Date: 2024-05-14
End Date: 2029-05
Study Type

Interventional

Study Phase

Phase3

No. of Participants

410

Intervention / Treatment

INBRX-106

Pembrolizumab

Sponsor

Inhibrx Biosciences, Inc

Source: clinicaltrials.gov

Share:
Add to list

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

Study ID: NCT06357182
Start Date: 2024-08-22
End Date: 2026-05-29
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Azacitidine

Biospecimen Collection

Bone Marrow Biopsy

Echocardiography

Iadademstat

Multigated Acquisition Scan

Administration questionnaire

Venetoclax

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list